Asthma management with the help of digital therapeutics: Review of clinical trials

Abstract

Digital therapeutics has emerged as a promising approach to manage chronic health conditions, including asthma. With the help of digital inhalers, mobile apps, and monitoring devices, patients can track their symptoms in real time and access personalized treatment plans remotely. Telemedicine and telemonitoring asthma have enabled health-care providers to monitor patient progress continuously while reducing the need for frequent office visits. Digital inhalers are one such example, providing patients with a complex therapeutic modality to self-administer. One such example is Propeller's digital platform helps asthma patients and their health-care providers record and monitor medication usage, review symptoms, and receive personalized interventions. A literature review was conducted to identify clinical trials reporting the use of digital tools for improving asthma outcomes, which showed that there are only monitoring tools available to improve asthma management through digital therapeutics at present. For example monitoring of adherance, asthma outcomes measurement. However, advancements in technology hold great potential for providing more comprehensive care by integrating data from multiple sources such as wearable sensors or electronic medical records into a single platform that could support better decision-making regarding patient care. The field of digital therapeutics is still evolving, but it holds immense promise for revolutionizing how we manage complex health conditions like asthma by empowering patients with effective tools that allow them to take control of their condition proactively.